HLL Lifecare Limited, a Mini-Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare, has paid a record dividend of Rs. 69.53 crore to the Government of India for the financial year 2024–25, one of the highest in the company’s history.
The dividend cheque was presented to J.P. Nadda, Union Minister of Health & Family Welfare, by Dr. Anitha Thampi, Chairperson of HLL, in the presence of Anupriya Patel, Minister of State for Health & Family Welfare, Punya Salila Srivastava, Union Health Secretary and other senior officials.
Speaking on the occasion, Shri Nadda described HLL as a “reliable hand in medical services” and commended its role in advancing accessible, affordable, and quality healthcare. Highlighting the impact of HLL and its subsidiaries, he noted that over the past decade, more than 6.7 crore people have benefited from affordable medicines at Amrit Pharmacies, saving over Rs. 8,000 crore in out-of-pocket expenses.
HLL’s strong financial performance is reflected in its operational revenue of Rs. 4,500 crore, a 20% growth from the previous year, with a net worth rising to Rs. 1,100 crore as of March 31, 2025. Including subsidiaries HITES, GAPL, and Lifespring Hospitals, the HLL Group recorded a consolidated revenue of Rs. 4,900 crore, a 19% increase over the previous fiscal.
Established in 1966, HLL Lifecare has evolved from focusing on population control to becoming a multi-product, multi-service healthcare enterprise. Through initiatives such as AMRIT Pharmacies, the company continues to provide affordable medicines and surgical products, reinforcing its commitment to equitable healthcare as it celebrates its 60th anniversary.
